Tiaa Fsb boosted its stake in Colgate-Palmolive (NYSE:CL) by 2.6% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 74,773 shares of the company’s stock after buying an additional 1,903 shares during the quarter. Tiaa Fsb’s holdings in Colgate-Palmolive were worth $5,006,000 as of its most recent filing with the SEC.
Other hedge funds also recently bought and sold shares of the company. A.R.T. Advisors LLC lifted its holdings in Colgate-Palmolive by 72.9% during the first quarter. A.R.T. Advisors LLC now owns 12,100 shares of the company’s stock valued at $867,000 after purchasing an additional 5,100 shares during the last quarter. Rainier Group Investment Advisory LLC purchased a new stake in Colgate-Palmolive during the first quarter valued at about $107,000. Private Capital Group LLC lifted its holdings in Colgate-Palmolive by 173.6% during the first quarter. Private Capital Group LLC now owns 2,353 shares of the company’s stock valued at $169,000 after purchasing an additional 1,493 shares during the last quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp purchased a new stake in Colgate-Palmolive during the first quarter valued at about $1,663,000. Finally, CIBC World Markets Inc. lifted its holdings in Colgate-Palmolive by 41.7% during the first quarter. CIBC World Markets Inc. now owns 94,185 shares of the company’s stock valued at $6,751,000 after purchasing an additional 27,731 shares during the last quarter. 74.95% of the stock is currently owned by hedge funds and other institutional investors.
Shares of CL opened at $64.52 on Friday. Colgate-Palmolive has a twelve month low of $61.28 and a twelve month high of $77.91. The stock has a market cap of $54.36 billion, a PE ratio of 20.95, a P/E/G ratio of 2.87 and a beta of 0.72. The company has a current ratio of 1.06, a quick ratio of 0.74 and a debt-to-equity ratio of -34.49.
The business also recently declared a quarterly dividend, which will be paid on Thursday, November 15th. Stockholders of record on Friday, October 19th will be given a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a dividend yield of 2.60%. The ex-dividend date is Thursday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 58.54%.
Several research firms have commented on CL. UBS Group set a $71.00 price objective on shares of Colgate-Palmolive and gave the company a “buy” rating in a report on Wednesday. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Friday, October 5th. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $75.00 to $73.00 and set a “hold” rating on the stock in a report on Monday, July 23rd. Wells Fargo & Co dropped their price objective on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating on the stock in a report on Wednesday. Finally, Citigroup dropped their price objective on shares of Colgate-Palmolive from $70.00 to $68.00 and set a “neutral” rating on the stock in a report on Tuesday, July 31st. Three analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $70.79.
In related news, Vice Chairman Dennis J. Hickey sold 120,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $65.72, for a total value of $7,886,400.00. Following the transaction, the insider now directly owns 202,414 shares in the company, valued at $13,302,648.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Philip G. Shotts sold 462 shares of the company’s stock in a transaction that occurred on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total transaction of $30,977.10. Following the completion of the transaction, the vice president now owns 41,250 shares in the company, valued at $2,765,812.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 395,779 shares of company stock worth $26,108,856. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Featured Story: Balance Sheet
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.